Global Proteomics Market

Proteomics Comprehensive Study by Application (Clinical Diagnostics, Drug Discovery, Other Applications), Services & Software (Core Proteomics Services, Bioinformatics Software & Services), Reagent (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents), Instrumentation Technology (Spectroscopy, Chromatography, Electrophoresis, Microfluidics, X-ray Crystallography, Others) Players and Region - Global Market Outlook to 2024

Proteomics Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 14.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Scope of the Study
Proteomics is the large scale study of proteomes that is a set of proteins formed in a system, organism, or biological context. For instance, it may refer the proteome of a species (such as, Homo sapiens) or an organ (such as, the liver). The proteome differs from cell to cell and changes over time, it is not constant. For some extent, the proteome reflects the underlying transcriptome. Growing popularity of personalized medicines, increasing R&D expenditure coupled with technological advancements related with proteomics are the factors that drives growth of global proteomics market. Additionally, growing awareness as well as availability of proteomics instruments in both developed & emerging market impels the market growth.

The market study is being classified, by Application (Clinical Diagnostics, Drug Discovery and Other Applications) and major geographies with country level break-up. According to AMA, the Global Proteomics market is expected to see growth rate of 14.6%

Thermo Fisher Scientific, Inc. (United States), Agilent Technologies, Inc. (United States), GE Healthcare (United States), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (United States), Danaher Corporation (United States), Luminex Corporation (United States), BioResource Biotech Pvt. Ltd. (India), Bruker Corporation (United States) and Waters Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Creative Proteomics (United States), Promega Corporation (United States), PerkinElmer, Inc. (United States) and Proteome Factory AG (Germany).

Research Analyst at AMA predicts that German, Indian, and United States Players will contribute to the maximum growth of Global Proteomics market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Proteomics market by Type, Application and Region.

On the basis of application, Drug Discovery segment is dominating the market in the year 2018

On the basis of geography, the market of Proteomics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. If we see Market by Services & Software, the sub-segment i.e. Core Proteomics Services will boost the Proteomics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Reagent, the sub-segment i.e. Immunoassay Reagents will boost the Proteomics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Instrumentation Technology, the sub-segment i.e. Spectroscopy will boost the Proteomics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Pharmaceutical & Biotechnology R&D Expenditure & Government Funding for Proteomics
  • Growing Demand Personalized Medicine
  • Proteomics Links the Gap between Genomics and Biochemistry


Restraints
  • High Cost of Instruments

Opportunities
  • Rising Prominence of Nanoproteomics, the Convergence of Nanotechnology & Proteomics
  • Personalized Proteomics for Precision Health
  • High Growth Opportunities in Emerging Nations

Challenges
  • Data Management in Proteomics Research


Market Leaders and their expansionary development strategies
In March 2019, Thermo Fisher Scientific Inc., and Brammer Bio, viral vector contract development and manufacturing organization (CDMO) have announced that they entered into a definitive agreement under which Thermo Fisher is likely to acquire Brammer Bio for approximately USD 1.7 Billion in cash. This transaction is likely to be completed by the end of the second quarter of 2019, is subject to customary closing conditions, with regulatory approvals. After the agreement completion, Brammer Bio will become part of Thermo Fisher's pharma services business within its Laboratory Products & Services Segment.



Key Target Audience
Proteomics Instruments Manufacturers, Proteomics Service and Software Providers, Proteomics Reagents Manufacturers, Raw Materials Suppliers, Government and Research Organizations, Industry Associations, End Users and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Application
  • Clinical Diagnostics
  • Drug Discovery
  • Other Applications
By Services & Software
  • Core Proteomics Services
  • Bioinformatics Software & Services

By Reagent
  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X-Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents

By Instrumentation Technology
  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Microfluidics
  • X-ray Crystallography
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Pharmaceutical & Biotechnology R&D Expenditure & Government Funding for Proteomics
      • 3.2.2. Growing Demand Personalized Medicine
      • 3.2.3. Proteomics Links the Gap between Genomics and Biochemistry
    • 3.3. Market Challenges
      • 3.3.1. Data Management in Proteomics Research
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Proteomics, by Application, Services & Software, Reagent, Instrumentation Technology and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Proteomics (Value)
      • 5.2.1. Global Proteomics by: Application (Value)
        • 5.2.1.1. Clinical Diagnostics
        • 5.2.1.2. Drug Discovery
        • 5.2.1.3. Other Applications
      • 5.2.2. Global Proteomics by: Services & Software (Value)
        • 5.2.2.1. Core Proteomics Services
        • 5.2.2.2. Bioinformatics Software & Services
      • 5.2.3. Global Proteomics by: Reagent (Value)
        • 5.2.3.1. Immunoassay Reagents
        • 5.2.3.2. Spectroscopy Reagents
        • 5.2.3.3. Chromatography Reagents
        • 5.2.3.4. Protein Microarray Reagents
        • 5.2.3.5. X-Ray Crystallography Reagents
        • 5.2.3.6. Electrophoresis Reagents
        • 5.2.3.7. Protein Fractionation Reagents
      • 5.2.4. Global Proteomics by: Instrumentation Technology (Value)
        • 5.2.4.1. Spectroscopy
        • 5.2.4.2. Chromatography
        • 5.2.4.3. Electrophoresis
        • 5.2.4.4. Microfluidics
        • 5.2.4.5. X-ray Crystallography
        • 5.2.4.6. Others
      • 5.2.5. Global Proteomics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Proteomics (Volume)
      • 5.3.1. Global Proteomics by: Application (Volume)
        • 5.3.1.1. Clinical Diagnostics
        • 5.3.1.2. Drug Discovery
        • 5.3.1.3. Other Applications
      • 5.3.2. Global Proteomics by: Services & Software (Volume)
        • 5.3.2.1. Core Proteomics Services
        • 5.3.2.2. Bioinformatics Software & Services
      • 5.3.3. Global Proteomics by: Reagent (Volume)
        • 5.3.3.1. Immunoassay Reagents
        • 5.3.3.2. Spectroscopy Reagents
        • 5.3.3.3. Chromatography Reagents
        • 5.3.3.4. Protein Microarray Reagents
        • 5.3.3.5. X-Ray Crystallography Reagents
        • 5.3.3.6. Electrophoresis Reagents
        • 5.3.3.7. Protein Fractionation Reagents
      • 5.3.4. Global Proteomics by: Instrumentation Technology (Volume)
        • 5.3.4.1. Spectroscopy
        • 5.3.4.2. Chromatography
        • 5.3.4.3. Electrophoresis
        • 5.3.4.4. Microfluidics
        • 5.3.4.5. X-ray Crystallography
        • 5.3.4.6. Others
      • 5.3.5. Global Proteomics Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Proteomics (Price)
  • 6. Proteomics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck KGaA (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Luminex Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioResource Biotech Pvt. Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bruker Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Waters Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Proteomics Sale, by Application, Services & Software, Reagent, Instrumentation Technology and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Proteomics (Value)
      • 7.2.1. Global Proteomics by: Application (Value)
        • 7.2.1.1. Clinical Diagnostics
        • 7.2.1.2. Drug Discovery
        • 7.2.1.3. Other Applications
      • 7.2.2. Global Proteomics by: Services & Software (Value)
        • 7.2.2.1. Core Proteomics Services
        • 7.2.2.2. Bioinformatics Software & Services
      • 7.2.3. Global Proteomics by: Reagent (Value)
        • 7.2.3.1. Immunoassay Reagents
        • 7.2.3.2. Spectroscopy Reagents
        • 7.2.3.3. Chromatography Reagents
        • 7.2.3.4. Protein Microarray Reagents
        • 7.2.3.5. X-Ray Crystallography Reagents
        • 7.2.3.6. Electrophoresis Reagents
        • 7.2.3.7. Protein Fractionation Reagents
      • 7.2.4. Global Proteomics by: Instrumentation Technology (Value)
        • 7.2.4.1. Spectroscopy
        • 7.2.4.2. Chromatography
        • 7.2.4.3. Electrophoresis
        • 7.2.4.4. Microfluidics
        • 7.2.4.5. X-ray Crystallography
        • 7.2.4.6. Others
      • 7.2.5. Global Proteomics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Proteomics (Volume)
      • 7.3.1. Global Proteomics by: Application (Volume)
        • 7.3.1.1. Clinical Diagnostics
        • 7.3.1.2. Drug Discovery
        • 7.3.1.3. Other Applications
      • 7.3.2. Global Proteomics by: Services & Software (Volume)
        • 7.3.2.1. Core Proteomics Services
        • 7.3.2.2. Bioinformatics Software & Services
      • 7.3.3. Global Proteomics by: Reagent (Volume)
        • 7.3.3.1. Immunoassay Reagents
        • 7.3.3.2. Spectroscopy Reagents
        • 7.3.3.3. Chromatography Reagents
        • 7.3.3.4. Protein Microarray Reagents
        • 7.3.3.5. X-Ray Crystallography Reagents
        • 7.3.3.6. Electrophoresis Reagents
        • 7.3.3.7. Protein Fractionation Reagents
      • 7.3.4. Global Proteomics by: Instrumentation Technology (Volume)
        • 7.3.4.1. Spectroscopy
        • 7.3.4.2. Chromatography
        • 7.3.4.3. Electrophoresis
        • 7.3.4.4. Microfluidics
        • 7.3.4.5. X-ray Crystallography
        • 7.3.4.6. Others
      • 7.3.5. Global Proteomics Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Proteomics (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Proteomics: by Application(USD Million)
  • Table 2. Proteomics Clinical Diagnostics , by Region USD Million (2013-2018)
  • Table 3. Proteomics Drug Discovery , by Region USD Million (2013-2018)
  • Table 4. Proteomics Other Applications , by Region USD Million (2013-2018)
  • Table 5. Proteomics: by Services & Software(USD Million)
  • Table 6. Proteomics Core Proteomics Services , by Region USD Million (2013-2018)
  • Table 7. Proteomics Bioinformatics Software & Services , by Region USD Million (2013-2018)
  • Table 8. Proteomics: by Reagent(USD Million)
  • Table 9. Proteomics Immunoassay Reagents , by Region USD Million (2013-2018)
  • Table 10. Proteomics Spectroscopy Reagents , by Region USD Million (2013-2018)
  • Table 11. Proteomics Chromatography Reagents , by Region USD Million (2013-2018)
  • Table 12. Proteomics Protein Microarray Reagents , by Region USD Million (2013-2018)
  • Table 13. Proteomics X-Ray Crystallography Reagents , by Region USD Million (2013-2018)
  • Table 14. Proteomics Electrophoresis Reagents , by Region USD Million (2013-2018)
  • Table 15. Proteomics Protein Fractionation Reagents , by Region USD Million (2013-2018)
  • Table 16. Proteomics: by Instrumentation Technology(USD Million)
  • Table 17. Proteomics Spectroscopy , by Region USD Million (2013-2018)
  • Table 18. Proteomics Chromatography , by Region USD Million (2013-2018)
  • Table 19. Proteomics Electrophoresis , by Region USD Million (2013-2018)
  • Table 20. Proteomics Microfluidics , by Region USD Million (2013-2018)
  • Table 21. Proteomics X-ray Crystallography , by Region USD Million (2013-2018)
  • Table 22. Proteomics Others , by Region USD Million (2013-2018)
  • Table 23. South America Proteomics, by Country USD Million (2013-2018)
  • Table 24. South America Proteomics, by Application USD Million (2013-2018)
  • Table 25. South America Proteomics, by Services & Software USD Million (2013-2018)
  • Table 26. South America Proteomics, by Reagent USD Million (2013-2018)
  • Table 27. South America Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 28. Brazil Proteomics, by Application USD Million (2013-2018)
  • Table 29. Brazil Proteomics, by Services & Software USD Million (2013-2018)
  • Table 30. Brazil Proteomics, by Reagent USD Million (2013-2018)
  • Table 31. Brazil Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 32. Argentina Proteomics, by Application USD Million (2013-2018)
  • Table 33. Argentina Proteomics, by Services & Software USD Million (2013-2018)
  • Table 34. Argentina Proteomics, by Reagent USD Million (2013-2018)
  • Table 35. Argentina Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 36. Rest of South America Proteomics, by Application USD Million (2013-2018)
  • Table 37. Rest of South America Proteomics, by Services & Software USD Million (2013-2018)
  • Table 38. Rest of South America Proteomics, by Reagent USD Million (2013-2018)
  • Table 39. Rest of South America Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 40. Asia Pacific Proteomics, by Country USD Million (2013-2018)
  • Table 41. Asia Pacific Proteomics, by Application USD Million (2013-2018)
  • Table 42. Asia Pacific Proteomics, by Services & Software USD Million (2013-2018)
  • Table 43. Asia Pacific Proteomics, by Reagent USD Million (2013-2018)
  • Table 44. Asia Pacific Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 45. China Proteomics, by Application USD Million (2013-2018)
  • Table 46. China Proteomics, by Services & Software USD Million (2013-2018)
  • Table 47. China Proteomics, by Reagent USD Million (2013-2018)
  • Table 48. China Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 49. Japan Proteomics, by Application USD Million (2013-2018)
  • Table 50. Japan Proteomics, by Services & Software USD Million (2013-2018)
  • Table 51. Japan Proteomics, by Reagent USD Million (2013-2018)
  • Table 52. Japan Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 53. India Proteomics, by Application USD Million (2013-2018)
  • Table 54. India Proteomics, by Services & Software USD Million (2013-2018)
  • Table 55. India Proteomics, by Reagent USD Million (2013-2018)
  • Table 56. India Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 57. South Korea Proteomics, by Application USD Million (2013-2018)
  • Table 58. South Korea Proteomics, by Services & Software USD Million (2013-2018)
  • Table 59. South Korea Proteomics, by Reagent USD Million (2013-2018)
  • Table 60. South Korea Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 61. Taiwan Proteomics, by Application USD Million (2013-2018)
  • Table 62. Taiwan Proteomics, by Services & Software USD Million (2013-2018)
  • Table 63. Taiwan Proteomics, by Reagent USD Million (2013-2018)
  • Table 64. Taiwan Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 65. Australia Proteomics, by Application USD Million (2013-2018)
  • Table 66. Australia Proteomics, by Services & Software USD Million (2013-2018)
  • Table 67. Australia Proteomics, by Reagent USD Million (2013-2018)
  • Table 68. Australia Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Proteomics, by Application USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Proteomics, by Services & Software USD Million (2013-2018)
  • Table 71. Rest of Asia-Pacific Proteomics, by Reagent USD Million (2013-2018)
  • Table 72. Rest of Asia-Pacific Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 73. Europe Proteomics, by Country USD Million (2013-2018)
  • Table 74. Europe Proteomics, by Application USD Million (2013-2018)
  • Table 75. Europe Proteomics, by Services & Software USD Million (2013-2018)
  • Table 76. Europe Proteomics, by Reagent USD Million (2013-2018)
  • Table 77. Europe Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 78. Germany Proteomics, by Application USD Million (2013-2018)
  • Table 79. Germany Proteomics, by Services & Software USD Million (2013-2018)
  • Table 80. Germany Proteomics, by Reagent USD Million (2013-2018)
  • Table 81. Germany Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 82. France Proteomics, by Application USD Million (2013-2018)
  • Table 83. France Proteomics, by Services & Software USD Million (2013-2018)
  • Table 84. France Proteomics, by Reagent USD Million (2013-2018)
  • Table 85. France Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 86. Italy Proteomics, by Application USD Million (2013-2018)
  • Table 87. Italy Proteomics, by Services & Software USD Million (2013-2018)
  • Table 88. Italy Proteomics, by Reagent USD Million (2013-2018)
  • Table 89. Italy Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 90. United Kingdom Proteomics, by Application USD Million (2013-2018)
  • Table 91. United Kingdom Proteomics, by Services & Software USD Million (2013-2018)
  • Table 92. United Kingdom Proteomics, by Reagent USD Million (2013-2018)
  • Table 93. United Kingdom Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 94. Netherlands Proteomics, by Application USD Million (2013-2018)
  • Table 95. Netherlands Proteomics, by Services & Software USD Million (2013-2018)
  • Table 96. Netherlands Proteomics, by Reagent USD Million (2013-2018)
  • Table 97. Netherlands Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 98. Rest of Europe Proteomics, by Application USD Million (2013-2018)
  • Table 99. Rest of Europe Proteomics, by Services & Software USD Million (2013-2018)
  • Table 100. Rest of Europe Proteomics, by Reagent USD Million (2013-2018)
  • Table 101. Rest of Europe Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 102. MEA Proteomics, by Country USD Million (2013-2018)
  • Table 103. MEA Proteomics, by Application USD Million (2013-2018)
  • Table 104. MEA Proteomics, by Services & Software USD Million (2013-2018)
  • Table 105. MEA Proteomics, by Reagent USD Million (2013-2018)
  • Table 106. MEA Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 107. Middle East Proteomics, by Application USD Million (2013-2018)
  • Table 108. Middle East Proteomics, by Services & Software USD Million (2013-2018)
  • Table 109. Middle East Proteomics, by Reagent USD Million (2013-2018)
  • Table 110. Middle East Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 111. Africa Proteomics, by Application USD Million (2013-2018)
  • Table 112. Africa Proteomics, by Services & Software USD Million (2013-2018)
  • Table 113. Africa Proteomics, by Reagent USD Million (2013-2018)
  • Table 114. Africa Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 115. North America Proteomics, by Country USD Million (2013-2018)
  • Table 116. North America Proteomics, by Application USD Million (2013-2018)
  • Table 117. North America Proteomics, by Services & Software USD Million (2013-2018)
  • Table 118. North America Proteomics, by Reagent USD Million (2013-2018)
  • Table 119. North America Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 120. United States Proteomics, by Application USD Million (2013-2018)
  • Table 121. United States Proteomics, by Services & Software USD Million (2013-2018)
  • Table 122. United States Proteomics, by Reagent USD Million (2013-2018)
  • Table 123. United States Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 124. Canada Proteomics, by Application USD Million (2013-2018)
  • Table 125. Canada Proteomics, by Services & Software USD Million (2013-2018)
  • Table 126. Canada Proteomics, by Reagent USD Million (2013-2018)
  • Table 127. Canada Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 128. Mexico Proteomics, by Application USD Million (2013-2018)
  • Table 129. Mexico Proteomics, by Services & Software USD Million (2013-2018)
  • Table 130. Mexico Proteomics, by Reagent USD Million (2013-2018)
  • Table 131. Mexico Proteomics, by Instrumentation Technology USD Million (2013-2018)
  • Table 132. Proteomics Sales: by Application(K Units)
  • Table 133. Proteomics Sales Clinical Diagnostics , by Region K Units (2013-2018)
  • Table 134. Proteomics Sales Drug Discovery , by Region K Units (2013-2018)
  • Table 135. Proteomics Sales Other Applications , by Region K Units (2013-2018)
  • Table 136. Proteomics Sales: by Services & Software(K Units)
  • Table 137. Proteomics Sales Core Proteomics Services , by Region K Units (2013-2018)
  • Table 138. Proteomics Sales Bioinformatics Software & Services , by Region K Units (2013-2018)
  • Table 139. Proteomics Sales: by Reagent(K Units)
  • Table 140. Proteomics Sales Immunoassay Reagents , by Region K Units (2013-2018)
  • Table 141. Proteomics Sales Spectroscopy Reagents , by Region K Units (2013-2018)
  • Table 142. Proteomics Sales Chromatography Reagents , by Region K Units (2013-2018)
  • Table 143. Proteomics Sales Protein Microarray Reagents , by Region K Units (2013-2018)
  • Table 144. Proteomics Sales X-Ray Crystallography Reagents , by Region K Units (2013-2018)
  • Table 145. Proteomics Sales Electrophoresis Reagents , by Region K Units (2013-2018)
  • Table 146. Proteomics Sales Protein Fractionation Reagents , by Region K Units (2013-2018)
  • Table 147. Proteomics Sales: by Instrumentation Technology(K Units)
  • Table 148. Proteomics Sales Spectroscopy , by Region K Units (2013-2018)
  • Table 149. Proteomics Sales Chromatography , by Region K Units (2013-2018)
  • Table 150. Proteomics Sales Electrophoresis , by Region K Units (2013-2018)
  • Table 151. Proteomics Sales Microfluidics , by Region K Units (2013-2018)
  • Table 152. Proteomics Sales X-ray Crystallography , by Region K Units (2013-2018)
  • Table 153. Proteomics Sales Others , by Region K Units (2013-2018)
  • Table 154. South America Proteomics Sales, by Country K Units (2013-2018)
  • Table 155. South America Proteomics Sales, by Application K Units (2013-2018)
  • Table 156. South America Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 157. South America Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 158. South America Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 159. Brazil Proteomics Sales, by Application K Units (2013-2018)
  • Table 160. Brazil Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 161. Brazil Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 162. Brazil Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 163. Argentina Proteomics Sales, by Application K Units (2013-2018)
  • Table 164. Argentina Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 165. Argentina Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 166. Argentina Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 167. Rest of South America Proteomics Sales, by Application K Units (2013-2018)
  • Table 168. Rest of South America Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 169. Rest of South America Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 170. Rest of South America Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 171. Asia Pacific Proteomics Sales, by Country K Units (2013-2018)
  • Table 172. Asia Pacific Proteomics Sales, by Application K Units (2013-2018)
  • Table 173. Asia Pacific Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 174. Asia Pacific Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 175. Asia Pacific Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 176. China Proteomics Sales, by Application K Units (2013-2018)
  • Table 177. China Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 178. China Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 179. China Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 180. Japan Proteomics Sales, by Application K Units (2013-2018)
  • Table 181. Japan Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 182. Japan Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 183. Japan Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 184. India Proteomics Sales, by Application K Units (2013-2018)
  • Table 185. India Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 186. India Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 187. India Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 188. South Korea Proteomics Sales, by Application K Units (2013-2018)
  • Table 189. South Korea Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 190. South Korea Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 191. South Korea Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 192. Taiwan Proteomics Sales, by Application K Units (2013-2018)
  • Table 193. Taiwan Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 194. Taiwan Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 195. Taiwan Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 196. Australia Proteomics Sales, by Application K Units (2013-2018)
  • Table 197. Australia Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 198. Australia Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 199. Australia Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 200. Rest of Asia-Pacific Proteomics Sales, by Application K Units (2013-2018)
  • Table 201. Rest of Asia-Pacific Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 202. Rest of Asia-Pacific Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 203. Rest of Asia-Pacific Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 204. Europe Proteomics Sales, by Country K Units (2013-2018)
  • Table 205. Europe Proteomics Sales, by Application K Units (2013-2018)
  • Table 206. Europe Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 207. Europe Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 208. Europe Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 209. Germany Proteomics Sales, by Application K Units (2013-2018)
  • Table 210. Germany Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 211. Germany Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 212. Germany Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 213. France Proteomics Sales, by Application K Units (2013-2018)
  • Table 214. France Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 215. France Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 216. France Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 217. Italy Proteomics Sales, by Application K Units (2013-2018)
  • Table 218. Italy Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 219. Italy Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 220. Italy Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 221. United Kingdom Proteomics Sales, by Application K Units (2013-2018)
  • Table 222. United Kingdom Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 223. United Kingdom Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 224. United Kingdom Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 225. Netherlands Proteomics Sales, by Application K Units (2013-2018)
  • Table 226. Netherlands Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 227. Netherlands Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 228. Netherlands Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 229. Rest of Europe Proteomics Sales, by Application K Units (2013-2018)
  • Table 230. Rest of Europe Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 231. Rest of Europe Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 232. Rest of Europe Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 233. MEA Proteomics Sales, by Country K Units (2013-2018)
  • Table 234. MEA Proteomics Sales, by Application K Units (2013-2018)
  • Table 235. MEA Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 236. MEA Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 237. MEA Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 238. Middle East Proteomics Sales, by Application K Units (2013-2018)
  • Table 239. Middle East Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 240. Middle East Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 241. Middle East Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 242. Africa Proteomics Sales, by Application K Units (2013-2018)
  • Table 243. Africa Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 244. Africa Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 245. Africa Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 246. North America Proteomics Sales, by Country K Units (2013-2018)
  • Table 247. North America Proteomics Sales, by Application K Units (2013-2018)
  • Table 248. North America Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 249. North America Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 250. North America Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 251. United States Proteomics Sales, by Application K Units (2013-2018)
  • Table 252. United States Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 253. United States Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 254. United States Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 255. Canada Proteomics Sales, by Application K Units (2013-2018)
  • Table 256. Canada Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 257. Canada Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 258. Canada Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 259. Mexico Proteomics Sales, by Application K Units (2013-2018)
  • Table 260. Mexico Proteomics Sales, by Services & Software K Units (2013-2018)
  • Table 261. Mexico Proteomics Sales, by Reagent K Units (2013-2018)
  • Table 262. Mexico Proteomics Sales, by Instrumentation Technology K Units (2013-2018)
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Proteomics: by Application(USD Million)
  • Table 274. Proteomics Clinical Diagnostics , by Region USD Million (2019-2024)
  • Table 275. Proteomics Drug Discovery , by Region USD Million (2019-2024)
  • Table 276. Proteomics Other Applications , by Region USD Million (2019-2024)
  • Table 277. Proteomics: by Services & Software(USD Million)
  • Table 278. Proteomics Core Proteomics Services , by Region USD Million (2019-2024)
  • Table 279. Proteomics Bioinformatics Software & Services , by Region USD Million (2019-2024)
  • Table 280. Proteomics: by Reagent(USD Million)
  • Table 281. Proteomics Immunoassay Reagents , by Region USD Million (2019-2024)
  • Table 282. Proteomics Spectroscopy Reagents , by Region USD Million (2019-2024)
  • Table 283. Proteomics Chromatography Reagents , by Region USD Million (2019-2024)
  • Table 284. Proteomics Protein Microarray Reagents , by Region USD Million (2019-2024)
  • Table 285. Proteomics X-Ray Crystallography Reagents , by Region USD Million (2019-2024)
  • Table 286. Proteomics Electrophoresis Reagents , by Region USD Million (2019-2024)
  • Table 287. Proteomics Protein Fractionation Reagents , by Region USD Million (2019-2024)
  • Table 288. Proteomics: by Instrumentation Technology(USD Million)
  • Table 289. Proteomics Spectroscopy , by Region USD Million (2019-2024)
  • Table 290. Proteomics Chromatography , by Region USD Million (2019-2024)
  • Table 291. Proteomics Electrophoresis , by Region USD Million (2019-2024)
  • Table 292. Proteomics Microfluidics , by Region USD Million (2019-2024)
  • Table 293. Proteomics X-ray Crystallography , by Region USD Million (2019-2024)
  • Table 294. Proteomics Others , by Region USD Million (2019-2024)
  • Table 295. South America Proteomics, by Country USD Million (2019-2024)
  • Table 296. South America Proteomics, by Application USD Million (2019-2024)
  • Table 297. South America Proteomics, by Services & Software USD Million (2019-2024)
  • Table 298. South America Proteomics, by Reagent USD Million (2019-2024)
  • Table 299. South America Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 300. Brazil Proteomics, by Application USD Million (2019-2024)
  • Table 301. Brazil Proteomics, by Services & Software USD Million (2019-2024)
  • Table 302. Brazil Proteomics, by Reagent USD Million (2019-2024)
  • Table 303. Brazil Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 304. Argentina Proteomics, by Application USD Million (2019-2024)
  • Table 305. Argentina Proteomics, by Services & Software USD Million (2019-2024)
  • Table 306. Argentina Proteomics, by Reagent USD Million (2019-2024)
  • Table 307. Argentina Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 308. Rest of South America Proteomics, by Application USD Million (2019-2024)
  • Table 309. Rest of South America Proteomics, by Services & Software USD Million (2019-2024)
  • Table 310. Rest of South America Proteomics, by Reagent USD Million (2019-2024)
  • Table 311. Rest of South America Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 312. Asia Pacific Proteomics, by Country USD Million (2019-2024)
  • Table 313. Asia Pacific Proteomics, by Application USD Million (2019-2024)
  • Table 314. Asia Pacific Proteomics, by Services & Software USD Million (2019-2024)
  • Table 315. Asia Pacific Proteomics, by Reagent USD Million (2019-2024)
  • Table 316. Asia Pacific Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 317. China Proteomics, by Application USD Million (2019-2024)
  • Table 318. China Proteomics, by Services & Software USD Million (2019-2024)
  • Table 319. China Proteomics, by Reagent USD Million (2019-2024)
  • Table 320. China Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 321. Japan Proteomics, by Application USD Million (2019-2024)
  • Table 322. Japan Proteomics, by Services & Software USD Million (2019-2024)
  • Table 323. Japan Proteomics, by Reagent USD Million (2019-2024)
  • Table 324. Japan Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 325. India Proteomics, by Application USD Million (2019-2024)
  • Table 326. India Proteomics, by Services & Software USD Million (2019-2024)
  • Table 327. India Proteomics, by Reagent USD Million (2019-2024)
  • Table 328. India Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 329. South Korea Proteomics, by Application USD Million (2019-2024)
  • Table 330. South Korea Proteomics, by Services & Software USD Million (2019-2024)
  • Table 331. South Korea Proteomics, by Reagent USD Million (2019-2024)
  • Table 332. South Korea Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 333. Taiwan Proteomics, by Application USD Million (2019-2024)
  • Table 334. Taiwan Proteomics, by Services & Software USD Million (2019-2024)
  • Table 335. Taiwan Proteomics, by Reagent USD Million (2019-2024)
  • Table 336. Taiwan Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 337. Australia Proteomics, by Application USD Million (2019-2024)
  • Table 338. Australia Proteomics, by Services & Software USD Million (2019-2024)
  • Table 339. Australia Proteomics, by Reagent USD Million (2019-2024)
  • Table 340. Australia Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 341. Rest of Asia-Pacific Proteomics, by Application USD Million (2019-2024)
  • Table 342. Rest of Asia-Pacific Proteomics, by Services & Software USD Million (2019-2024)
  • Table 343. Rest of Asia-Pacific Proteomics, by Reagent USD Million (2019-2024)
  • Table 344. Rest of Asia-Pacific Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 345. Europe Proteomics, by Country USD Million (2019-2024)
  • Table 346. Europe Proteomics, by Application USD Million (2019-2024)
  • Table 347. Europe Proteomics, by Services & Software USD Million (2019-2024)
  • Table 348. Europe Proteomics, by Reagent USD Million (2019-2024)
  • Table 349. Europe Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 350. Germany Proteomics, by Application USD Million (2019-2024)
  • Table 351. Germany Proteomics, by Services & Software USD Million (2019-2024)
  • Table 352. Germany Proteomics, by Reagent USD Million (2019-2024)
  • Table 353. Germany Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 354. France Proteomics, by Application USD Million (2019-2024)
  • Table 355. France Proteomics, by Services & Software USD Million (2019-2024)
  • Table 356. France Proteomics, by Reagent USD Million (2019-2024)
  • Table 357. France Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 358. Italy Proteomics, by Application USD Million (2019-2024)
  • Table 359. Italy Proteomics, by Services & Software USD Million (2019-2024)
  • Table 360. Italy Proteomics, by Reagent USD Million (2019-2024)
  • Table 361. Italy Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 362. United Kingdom Proteomics, by Application USD Million (2019-2024)
  • Table 363. United Kingdom Proteomics, by Services & Software USD Million (2019-2024)
  • Table 364. United Kingdom Proteomics, by Reagent USD Million (2019-2024)
  • Table 365. United Kingdom Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 366. Netherlands Proteomics, by Application USD Million (2019-2024)
  • Table 367. Netherlands Proteomics, by Services & Software USD Million (2019-2024)
  • Table 368. Netherlands Proteomics, by Reagent USD Million (2019-2024)
  • Table 369. Netherlands Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 370. Rest of Europe Proteomics, by Application USD Million (2019-2024)
  • Table 371. Rest of Europe Proteomics, by Services & Software USD Million (2019-2024)
  • Table 372. Rest of Europe Proteomics, by Reagent USD Million (2019-2024)
  • Table 373. Rest of Europe Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 374. MEA Proteomics, by Country USD Million (2019-2024)
  • Table 375. MEA Proteomics, by Application USD Million (2019-2024)
  • Table 376. MEA Proteomics, by Services & Software USD Million (2019-2024)
  • Table 377. MEA Proteomics, by Reagent USD Million (2019-2024)
  • Table 378. MEA Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 379. Middle East Proteomics, by Application USD Million (2019-2024)
  • Table 380. Middle East Proteomics, by Services & Software USD Million (2019-2024)
  • Table 381. Middle East Proteomics, by Reagent USD Million (2019-2024)
  • Table 382. Middle East Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 383. Africa Proteomics, by Application USD Million (2019-2024)
  • Table 384. Africa Proteomics, by Services & Software USD Million (2019-2024)
  • Table 385. Africa Proteomics, by Reagent USD Million (2019-2024)
  • Table 386. Africa Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 387. North America Proteomics, by Country USD Million (2019-2024)
  • Table 388. North America Proteomics, by Application USD Million (2019-2024)
  • Table 389. North America Proteomics, by Services & Software USD Million (2019-2024)
  • Table 390. North America Proteomics, by Reagent USD Million (2019-2024)
  • Table 391. North America Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 392. United States Proteomics, by Application USD Million (2019-2024)
  • Table 393. United States Proteomics, by Services & Software USD Million (2019-2024)
  • Table 394. United States Proteomics, by Reagent USD Million (2019-2024)
  • Table 395. United States Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 396. Canada Proteomics, by Application USD Million (2019-2024)
  • Table 397. Canada Proteomics, by Services & Software USD Million (2019-2024)
  • Table 398. Canada Proteomics, by Reagent USD Million (2019-2024)
  • Table 399. Canada Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 400. Mexico Proteomics, by Application USD Million (2019-2024)
  • Table 401. Mexico Proteomics, by Services & Software USD Million (2019-2024)
  • Table 402. Mexico Proteomics, by Reagent USD Million (2019-2024)
  • Table 403. Mexico Proteomics, by Instrumentation Technology USD Million (2019-2024)
  • Table 404. Proteomics Sales: by Application(K Units)
  • Table 405. Proteomics Sales Clinical Diagnostics , by Region K Units (2019-2024)
  • Table 406. Proteomics Sales Drug Discovery , by Region K Units (2019-2024)
  • Table 407. Proteomics Sales Other Applications , by Region K Units (2019-2024)
  • Table 408. Proteomics Sales: by Services & Software(K Units)
  • Table 409. Proteomics Sales Core Proteomics Services , by Region K Units (2019-2024)
  • Table 410. Proteomics Sales Bioinformatics Software & Services , by Region K Units (2019-2024)
  • Table 411. Proteomics Sales: by Reagent(K Units)
  • Table 412. Proteomics Sales Immunoassay Reagents , by Region K Units (2019-2024)
  • Table 413. Proteomics Sales Spectroscopy Reagents , by Region K Units (2019-2024)
  • Table 414. Proteomics Sales Chromatography Reagents , by Region K Units (2019-2024)
  • Table 415. Proteomics Sales Protein Microarray Reagents , by Region K Units (2019-2024)
  • Table 416. Proteomics Sales X-Ray Crystallography Reagents , by Region K Units (2019-2024)
  • Table 417. Proteomics Sales Electrophoresis Reagents , by Region K Units (2019-2024)
  • Table 418. Proteomics Sales Protein Fractionation Reagents , by Region K Units (2019-2024)
  • Table 419. Proteomics Sales: by Instrumentation Technology(K Units)
  • Table 420. Proteomics Sales Spectroscopy , by Region K Units (2019-2024)
  • Table 421. Proteomics Sales Chromatography , by Region K Units (2019-2024)
  • Table 422. Proteomics Sales Electrophoresis , by Region K Units (2019-2024)
  • Table 423. Proteomics Sales Microfluidics , by Region K Units (2019-2024)
  • Table 424. Proteomics Sales X-ray Crystallography , by Region K Units (2019-2024)
  • Table 425. Proteomics Sales Others , by Region K Units (2019-2024)
  • Table 426. South America Proteomics Sales, by Country K Units (2019-2024)
  • Table 427. South America Proteomics Sales, by Application K Units (2019-2024)
  • Table 428. South America Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 429. South America Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 430. South America Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 431. Brazil Proteomics Sales, by Application K Units (2019-2024)
  • Table 432. Brazil Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 433. Brazil Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 434. Brazil Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 435. Argentina Proteomics Sales, by Application K Units (2019-2024)
  • Table 436. Argentina Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 437. Argentina Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 438. Argentina Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 439. Rest of South America Proteomics Sales, by Application K Units (2019-2024)
  • Table 440. Rest of South America Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 441. Rest of South America Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 442. Rest of South America Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 443. Asia Pacific Proteomics Sales, by Country K Units (2019-2024)
  • Table 444. Asia Pacific Proteomics Sales, by Application K Units (2019-2024)
  • Table 445. Asia Pacific Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 446. Asia Pacific Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 447. Asia Pacific Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 448. China Proteomics Sales, by Application K Units (2019-2024)
  • Table 449. China Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 450. China Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 451. China Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 452. Japan Proteomics Sales, by Application K Units (2019-2024)
  • Table 453. Japan Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 454. Japan Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 455. Japan Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 456. India Proteomics Sales, by Application K Units (2019-2024)
  • Table 457. India Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 458. India Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 459. India Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 460. South Korea Proteomics Sales, by Application K Units (2019-2024)
  • Table 461. South Korea Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 462. South Korea Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 463. South Korea Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 464. Taiwan Proteomics Sales, by Application K Units (2019-2024)
  • Table 465. Taiwan Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 466. Taiwan Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 467. Taiwan Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 468. Australia Proteomics Sales, by Application K Units (2019-2024)
  • Table 469. Australia Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 470. Australia Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 471. Australia Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 472. Rest of Asia-Pacific Proteomics Sales, by Application K Units (2019-2024)
  • Table 473. Rest of Asia-Pacific Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 474. Rest of Asia-Pacific Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 475. Rest of Asia-Pacific Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 476. Europe Proteomics Sales, by Country K Units (2019-2024)
  • Table 477. Europe Proteomics Sales, by Application K Units (2019-2024)
  • Table 478. Europe Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 479. Europe Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 480. Europe Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 481. Germany Proteomics Sales, by Application K Units (2019-2024)
  • Table 482. Germany Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 483. Germany Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 484. Germany Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 485. France Proteomics Sales, by Application K Units (2019-2024)
  • Table 486. France Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 487. France Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 488. France Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 489. Italy Proteomics Sales, by Application K Units (2019-2024)
  • Table 490. Italy Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 491. Italy Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 492. Italy Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 493. United Kingdom Proteomics Sales, by Application K Units (2019-2024)
  • Table 494. United Kingdom Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 495. United Kingdom Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 496. United Kingdom Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 497. Netherlands Proteomics Sales, by Application K Units (2019-2024)
  • Table 498. Netherlands Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 499. Netherlands Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 500. Netherlands Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 501. Rest of Europe Proteomics Sales, by Application K Units (2019-2024)
  • Table 502. Rest of Europe Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 503. Rest of Europe Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 504. Rest of Europe Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 505. MEA Proteomics Sales, by Country K Units (2019-2024)
  • Table 506. MEA Proteomics Sales, by Application K Units (2019-2024)
  • Table 507. MEA Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 508. MEA Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 509. MEA Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 510. Middle East Proteomics Sales, by Application K Units (2019-2024)
  • Table 511. Middle East Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 512. Middle East Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 513. Middle East Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 514. Africa Proteomics Sales, by Application K Units (2019-2024)
  • Table 515. Africa Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 516. Africa Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 517. Africa Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 518. North America Proteomics Sales, by Country K Units (2019-2024)
  • Table 519. North America Proteomics Sales, by Application K Units (2019-2024)
  • Table 520. North America Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 521. North America Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 522. North America Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 523. United States Proteomics Sales, by Application K Units (2019-2024)
  • Table 524. United States Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 525. United States Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 526. United States Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 527. Canada Proteomics Sales, by Application K Units (2019-2024)
  • Table 528. Canada Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 529. Canada Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 530. Canada Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 531. Mexico Proteomics Sales, by Application K Units (2019-2024)
  • Table 532. Mexico Proteomics Sales, by Services & Software K Units (2019-2024)
  • Table 533. Mexico Proteomics Sales, by Reagent K Units (2019-2024)
  • Table 534. Mexico Proteomics Sales, by Instrumentation Technology K Units (2019-2024)
  • Table 535. Research Programs/Design for This Report
  • Table 536. Key Data Information from Secondary Sources
  • Table 537. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Proteomics: by Application USD Million (2013-2018)
  • Figure 5. Global Proteomics: by Services & Software USD Million (2013-2018)
  • Figure 6. Global Proteomics: by Reagent USD Million (2013-2018)
  • Figure 7. Global Proteomics: by Instrumentation Technology USD Million (2013-2018)
  • Figure 8. South America Proteomics Share (%), by Country
  • Figure 9. Asia Pacific Proteomics Share (%), by Country
  • Figure 10. Europe Proteomics Share (%), by Country
  • Figure 11. MEA Proteomics Share (%), by Country
  • Figure 12. North America Proteomics Share (%), by Country
  • Figure 13. Global Proteomics: by Application K Units (2013-2018)
  • Figure 14. Global Proteomics: by Services & Software K Units (2013-2018)
  • Figure 15. Global Proteomics: by Reagent K Units (2013-2018)
  • Figure 16. Global Proteomics: by Instrumentation Technology K Units (2013-2018)
  • Figure 17. South America Proteomics Share (%), by Country
  • Figure 18. Asia Pacific Proteomics Share (%), by Country
  • Figure 19. Europe Proteomics Share (%), by Country
  • Figure 20. MEA Proteomics Share (%), by Country
  • Figure 21. North America Proteomics Share (%), by Country
  • Figure 22. Global Proteomics share by Players 2018 (%)
  • Figure 23. Global Proteomics share by Players (Top 3) 2018(%)
  • Figure 24. Global Proteomics share by Players (Top 5) 2018(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2018
  • Figure 28. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies, Inc. (United States) Revenue: by Geography 2018
  • Figure 30. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 31. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 32. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Merck KGaA (Germany) Revenue: by Geography 2018
  • Figure 34. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 36. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 37. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 38. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 39. Luminex Corporation (United States) Revenue: by Geography 2018
  • Figure 40. BioResource Biotech Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 41. BioResource Biotech Pvt. Ltd. (India) Revenue: by Geography 2018
  • Figure 42. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 43. Bruker Corporation (United States) Revenue: by Geography 2018
  • Figure 44. Waters Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 45. Waters Corporation (United States) Revenue: by Geography 2018
  • Figure 46. Global Proteomics: by Application USD Million (2019-2024)
  • Figure 47. Global Proteomics: by Services & Software USD Million (2019-2024)
  • Figure 48. Global Proteomics: by Reagent USD Million (2019-2024)
  • Figure 49. Global Proteomics: by Instrumentation Technology USD Million (2019-2024)
  • Figure 50. South America Proteomics Share (%), by Country
  • Figure 51. Asia Pacific Proteomics Share (%), by Country
  • Figure 52. Europe Proteomics Share (%), by Country
  • Figure 53. MEA Proteomics Share (%), by Country
  • Figure 54. North America Proteomics Share (%), by Country
  • Figure 55. Global Proteomics: by Application K Units (2019-2024)
  • Figure 56. Global Proteomics: by Services & Software K Units (2019-2024)
  • Figure 57. Global Proteomics: by Reagent K Units (2019-2024)
  • Figure 58. Global Proteomics: by Instrumentation Technology K Units (2019-2024)
  • Figure 59. South America Proteomics Share (%), by Country
  • Figure 60. Asia Pacific Proteomics Share (%), by Country
  • Figure 61. Europe Proteomics Share (%), by Country
  • Figure 62. MEA Proteomics Share (%), by Country
  • Figure 63. North America Proteomics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • GE Healthcare (United States)
  • Merck KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (United States)
  • Danaher Corporation (United States)
  • Luminex Corporation (United States)
  • BioResource Biotech Pvt. Ltd. (India)
  • Bruker Corporation (United States)
  • Waters Corporation (United States)
Additional players considered in the study are as follows:
Creative Proteomics (United States) , Promega Corporation (United States) , PerkinElmer, Inc. (United States) , Proteome Factory AG (Germany)
Select User Access Type

Key Highlights of Report


Mar 2019 234 Pages 67 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Proteomics Market Quantitative research analysis
Global Proteomics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Proteomics Market Report?

Have a Query? Click Here

Other Related Reports

3D Cell Cultures Comprehensive Study by Type (Membrane Type, Foam / gel Type, Microcarriers Type), Application (Tissue Engineering, Tumor Model, Stem Cell Research, Drug Discovery, Regenerative Medic...
$ 3750
Medical Biomimetics Comprehensive Study by Type (Cardiovascular, Orthopedic (Prostheses, Exoskeleton), Ophthalmology, Dental, Others), Application (Wound Healing, Tissue Engineering, Drug Delivery, P...
$ 3350
Antimicrobial Susceptibility Testing Comprehensive Study by Type (Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility T...
$ 3750
Peptides Comprehensive Study by Type (Custom (Standard , Quant , Cyclic Custom , Others), Catalog (Neuroscience, Cardiovascular, Diabetes, Others)), Application (Commercial, Academic Research, Therap...
$ 3450
DNA and Gene Chip Comprehensive Study by Type (Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}, CDNA Chips {Mechanical M...
$ 3750
Extremity Tissue Expander Comprehensive Study by Type (Upper extremities, Lower extremities), Application (Breast reconstruction, Scalp reconstruction, Oral and maxillofacial reconstruction, Paediatr...
$ 3650